Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats.
Nurmio, Mirja
Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats. [electronic resource] - Toxicology and applied pharmacology Aug 2011 - 267-79 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2011.04.019 doi
Animals
Benzamides
Bone Development--drug effects
Bone Resorption--chemically induced
Imatinib Mesylate
Male
Osteogenesis--drug effects
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Pyrimidines--pharmacology
Rats
Rats, Sprague-Dawley
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors
Receptor tyrosine kinase inhibition causes simultaneous bone loss and excess bone formation within growing bone in rats. [electronic resource] - Toxicology and applied pharmacology Aug 2011 - 267-79 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1096-0333
10.1016/j.taap.2011.04.019 doi
Animals
Benzamides
Bone Development--drug effects
Bone Resorption--chemically induced
Imatinib Mesylate
Male
Osteogenesis--drug effects
Piperazines--pharmacology
Protein Kinase Inhibitors--pharmacology
Pyrimidines--pharmacology
Rats
Rats, Sprague-Dawley
Receptor Protein-Tyrosine Kinases--antagonists & inhibitors